Optimizing In Situ Vaccination
During Radiotherapy

 

Frontiers in Oncology
 

October 26, 2021

Boosting the Abscopal Effect Using
Immunogenic Biomaterials With
Varying Radiation Therapy
Field Sizes

International Journal of Radiation
Oncology, Biology, Physics

September 13, 2021

Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer

Frontiers in Immunology
 

September 7, 2018

Enhancing the Therapeutic
Efficacy of Cancer Treatment
with Cannabinoids


Frontiers in Oncology

April 24, 2018

Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants

Frontiers in Oncology

March 12, 2018

Using Immunotherapy to Boost Abscopal Effect



Nature Reviews Cancer

February 16, 2018

Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids


Frontiers in Oncology

September 19, 2017

Modeling Gold Nanoparticle-Eluting Spacer Degradation During Brachytherapy Application with In-Situ Dose Painting

British Journal of Radiology

June 6, 2017

Enhancing Radiotherapy for Lung Cancer Using Immunoadjuvants Delivered In-Situ from New Design Radiotherapy Biomaterials

Physics in Medicine and Biology

December 2, 2016

Smart Radiotherapy Biomaterials, A Preclinical Study


International Journal of Radiation Oncology, Biology, Physics

November 1, 2016

Potential for Enhancing External Beam Radiotherapy for Lung Cancer Using High-Z Nanoparticles Administered Via Inhalation

Physics in Medicine and Biology

August 26, 2015

Nanocan Named One of Pepperdine’s
2022 Most Fundable Companies


Business Wire

October 13, 2022

Appointment Of Dr. Elder Granger and Dr. Paul Wallner To Advisory Board


AP NEWS

November 21, 2021

Exclusive Global Licensing Agreement for Immunogenic Smart Radiotherapy Biomaterials

PRWeb

February 16, 2021

Nanocan Therapeutics Corporation Announces Funding Round


PRWeb

November 23, 2020